Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation
Authors:
Abstract
Hepatobiliary cystadenomas with mesenchymal stroma (CMS) are rare tumors. Two cases are reported that illustrate many features of CMS, including polypoid involvement of the common hepatic duct in one case. Both tumors were associated with elevated serum levels of the tumor-associated antigen CA 19-9 but normal levels of carcinoembryonic antigen and alpha-fetoprotein. Immunohistochemical analysis confirmed the presence of CA 19-9 in the epithelial component of the tumor. The implications of these findings are discussed, both in relation to the histogenesis of CMS and its preoperative diagnosis. A minimally elevated level of CA 19-9 was found in only one of five patients with hydatid disease of the liver, an important differential diagnosis in clinical management. Cancer 1992; 70:1841–1846.Keywords
This publication has 7 references indexed in Scilit:
- Hepatobiliary Cystadenoma with Mesenchymal StromaAnnals of Surgery, 1990
- Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findingsAmerican Journal of Roentgenology, 1989
- Surgical Treatment of Biliary CystadenomaArchives of Surgery, 1988
- Imaging diagnosis of bile duct cystadenocarcinomaCancer, 1988
- Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant changeCancer, 1985
- Biliary cystadenoma and cystadenocarcinoma.Report of 14 cases and review of the literatureCancer, 1977
- Solitary nonparasitic Cyst of the LiverA.M.A. Archives of Surgery, 1955